GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ProSomnus Inc (OTCPK:OSAPQ) » Definitions » FCF Margin %

ProSomnus (ProSomnus) FCF Margin % : -68.58% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is ProSomnus FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ProSomnus's Free Cash Flow for the three months ended in Dec. 2023 was $-5.38 Mil. ProSomnus's Revenue for the three months ended in Dec. 2023 was $7.84 Mil. Therefore, ProSomnus's FCF Margin % for the quarter that ended in Dec. 2023 was -68.58%.

As of today, ProSomnus's current FCF Yield % is -2,524.25%.

The historical rank and industry rank for ProSomnus's FCF Margin % or its related term are showing as below:

OSAPQ' s FCF Margin % Range Over the Past 10 Years
Min: -63.63   Med: -53.25   Max: -35.07
Current: -63.63


During the past 4 years, the highest FCF Margin % of ProSomnus was -35.07%. The lowest was -63.63%. And the median was -53.25%.

OSAPQ's FCF Margin % is ranked worse than
72.79% of 827 companies
in the Medical Devices & Instruments industry
Industry Median: -7.24 vs OSAPQ: -63.63


ProSomnus FCF Margin % Historical Data

The historical data trend for ProSomnus's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProSomnus FCF Margin % Chart

ProSomnus Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Margin %
-46.71 -35.07 -59.78 -63.63

ProSomnus Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -112.22 -70.02 -71.16 -45.51 -68.58

Competitive Comparison of ProSomnus's FCF Margin %

For the Medical Devices subindustry, ProSomnus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProSomnus's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ProSomnus's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ProSomnus's FCF Margin % falls into.



ProSomnus FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ProSomnus's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-17.594/27.652
=-63.63 %

ProSomnus's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-5.375/7.838
=-68.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ProSomnus FCF Margin % Related Terms

Thank you for viewing the detailed overview of ProSomnus's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ProSomnus (ProSomnus) Business Description

Traded in Other Exchanges
N/A
Address
5675 Gibraltar Drive, Pleasanton, CA, USA, 94588
ProSomnus Inc is a medical device manufacturer. It manufacturers precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus's patented devices are more comfortable and less invasive alternative to continuous positive airway pressure therapy, and lead to more effective and patient-preferred outcomes.
Executives
Sung Kim officer: Chief Technical Officer 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
John Steffens 10 percent owner C/O DIGITALBRIDGE GROUP, INC., 750 PARK OF COMMERCE DRIVE SUITE 210, BOCCA RATON FL 33487
Gregory P. Ho 10 percent owner C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Brian B Dow officer: Chief Financial Officer 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Smc Holdings Ii, Lp 10 percent owner 65 EAST 55TH STREET, 33RD FLOOR, NEW YORK NY 10022
Smc Holdings Ii G.p., Llc 10 percent owner C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Laing Rikkers director 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Len Liptak director, officer: Chief Executive Officer 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Mark Thomas Murphy officer: Chief Growth Officer 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Hgp Iii, Llc 10 percent owner 3708 ASHFORD PLACE, GREENVILLE NC 27858
Steven Robert Pacelli director 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Hmc, Llc 10 percent owner 3708 ASHFORD PLACE, GREENVILLE NC 27858
Healthpointcapital, Llc 10 percent owner C/O HEALTHPOINTCAPITAL, 505 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Healthpointcapital Partners Iii Lp 10 percent owner 505 Park Avenue, 12th Floor, New York NY 10022
Leonard Hedge director 7855 BELLA MONTANIA LANE, PALO CEDRO CA 96073

ProSomnus (ProSomnus) Headlines

From GuruFocus

Q4 2022 Prosomnus Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q2 2023 Prosomnus Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024